Impact of clinical risk category on prognosis and prediction of chemotherapy benefit in early breast cancer (EBC) by age and the 21-gene recurrence score (RS) in TAILORx - Sparano, JA; Gray, RJ; Makower, DF (J Clin Oncol, 2019)
et al.